HDAC inhibitors (HDACIs) have great potential for treating cancers, immunological diseases and other conditions [28, 29] as they can block angiogenesis, arrest cell growth and lead to differentiation and apoptosis in tumor cells [30]. This evidence concerns the gene HDAC9 and cancer.